US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

OSA

ProSomnus (OSA)

ProSomnus Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:OSA

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/03/27	05 : 05	GlobeNewswire Inc.	ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results	NASDAQ:OSA	ProSomnus Inc
2024/03/18	20 : 12	IH Market News	Anticipation Builds on Wall Street for Federal Reserve’s Upcoming Policy Moves; WTI and Brent See Upticks	NASDAQ:OSA	ProSomnus Inc
2024/03/16	09 : 01	GlobeNewswire Inc.	ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call	NASDAQ:OSA	ProSomnus Inc
2024/02/22	22 : 30	GlobeNewswire Inc.	ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea	NASDAQ:OSA	ProSomnus Inc
2024/02/21	06 : 05	GlobeNewswire Inc.	ProSomnus Announces Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call and Participation at the 36th Annual ROTH Conference in March 2024	NASDAQ:OSA	ProSomnus Inc
2024/01/30	22 : 00	GlobeNewswire Inc.	ProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDA	NASDAQ:OSA	ProSomnus Inc
2024/01/29	22 : 00	GlobeNewswire Inc.	ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices	NASDAQ:OSA	ProSomnus Inc
2024/01/08	22 : 00	GlobeNewswire Inc.	ProSomnus Comments on Insurance Coverage Policy Update for Obstructive and Central Sleep Apnea	NASDAQ:OSA	ProSomnus Inc
2023/12/19	22 : 00	GlobeNewswire Inc.	Data Published by Cureus Journal of Medical Science Shows Successful Treatment of Obstructive Sleep Apnea with ProSomnus Precision Oral Appliance Devices	NASDAQ:OSA	ProSomnus Inc
2023/11/10	06 : 17	GlobeNewswire Inc.	ProSomnus, the Leading Non-CPAP Obstructive Sleep Apnea Therapy, Reports Record Third Quarter 2023 Financial Results	NASDAQ:OSA	ProSomnus Inc
2023/11/01	05 : 05	GlobeNewswire Inc.	ProSomnus Announces Third Quarter 2023 Investor Call and Business Update	NASDAQ:OSA	ProSomnus Inc
2023/10/04	05 : 05	GlobeNewswire Inc.	ProSomnus Announces Participation in the 2023 Roth Capital Healthcare Opportunities Conference	NASDAQ:OSA	ProSomnus Inc
2023/09/21	21 : 30	GlobeNewswire Inc.	ProSomnus Raises $10 Million To Fuel Growth and Optimize Operations	NASDAQ:OSA	ProSomnus Inc
2023/09/14	21 : 30	GlobeNewswire Inc.	ProSomnus Precision Obstructive Sleep Apnea Devices to be Featured in Scientific Abstracts and Podium Presentations at Upcoming Medical Conferences	NASDAQ:OSA	ProSomnus Inc
2023/08/23	21 : 00	GlobeNewswire Inc.	Updated Clinical Trial Data Indicates Precision Oral Appliance Therapy with ProSomnus Devices is Non-Inferior to CPAP Therapy for the Treatment of Moderate to Severe Obstructive Sleep Apnea	NASDAQ:OSA	ProSomnus Inc
2023/08/03	21 : 09	GlobeNewswire Inc.	ProSomnus Reports Record Second Quarter 2023 Top-Line Financial Results	NASDAQ:OSA	ProSomnus Inc
2023/07/13	21 : 00	GlobeNewswire Inc.	ProSomnus to Design Head-to-Head Clinical Trial vs. Hypoglossal Nerve Stimulation	NASDAQ:OSA	ProSomnus Inc
2023/07/06	21 : 29	GlobeNewswire Inc.	ProSomnus Announces Second Quarter 2023 Investor Call and Business Update	NASDAQ:OSA	ProSomnus Inc
2023/06/28	21 : 00	GlobeNewswire Inc.	71% of Self-identified Snorers Have Never Consulted a Healthcare Professional	NASDAQ:OSA	ProSomnus Inc
2023/06/09	05 : 08	GlobeNewswire Inc.	Data Presented at the 2023 SLEEP Annual Meeting Strengthens Evidence for ProSomnus Precision Oral Appliance Therapy for the Treatment of Obstructive Sleep Apnea	NASDAQ:OSA	ProSomnus Inc
2023/05/30	21 : 00	GlobeNewswire Inc.	Data Presented at the 2023 American Academy of Dental Sleep Medicine and the American Thoracic Society Meetings Further Validate ProSomnus Precision Oral Appliance Therapy for the Treatment of Obstructive Sleep Apnea	NASDAQ:OSA	ProSomnus Inc
2023/05/10	05 : 00	GlobeNewswire Inc.	ProSomnus Reports First Quarter 2023 Financial Results	NASDAQ:OSA	ProSomnus Inc
2023/04/26	22 : 00	GlobeNewswire Inc.	ProSomnus Announces Q1 2023 Investor Call and Participation in Upcoming Investor Conferences	NASDAQ:OSA	ProSomnus Inc
2023/04/25	05 : 05	GlobeNewswire Inc.	Study to be Presented at European Respiratory Society and European Sleep Research Society’s Sleep and Breathing 2023 Conference Demonstrates Efficacy of ProSomnus Precision Oral Appliances	NASDAQ:OSA	ProSomnus Inc
2023/04/18	21 : 00	GlobeNewswire Inc.	ProSomnus® Announces Publication of Four Accepted Abstracts in the Journal of Dental Sleep Medicine in Advance of Annual Meeting	NASDAQ:OSA	ProSomnus Inc
2023/04/05	21 : 00	GlobeNewswire Inc.	ProSomnus® Receives Additional U.S. Utility Patent Covering Iterative Titration Technology for Company’s Novel Precision Sleep Apnea Medical Devices	NASDAQ:OSA	ProSomnus Inc
2023/03/31	05 : 05	GlobeNewswire Inc.	ProSomnus Reports Fourth Quarter and Fiscal Year 2022 Financial Results	NASDAQ:OSA	ProSomnus Inc
2023/03/21	21 : 00	GlobeNewswire Inc.	ProSomnus® Receives Patent Allowance Covering Automated Manufacturing Process for Company’s Novel Precision Sleep Apnea Medical Devices	NASDAQ:OSA	ProSomnus Inc
2023/03/17	05 : 05	GlobeNewswire Inc.	ProSomnus to Host Investor Call and Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023	NASDAQ:OSA	ProSomnus Inc
2023/03/10	22 : 00	GlobeNewswire Inc.	ProSomnus® Announces Acceptance of Abstract at European Respiratory Society and European Sleep Research Society’s Sleep and Breathing 2023 Conference	NASDAQ:OSA	ProSomnus Inc

Showing the most relevant articles for your search:NASDAQ:OSA

Verizon Communications

American Express

Invesco QQQ Trust Series 1

US Dollar vs Yen

Deutsche Telekom (QX)

US Dollar vs Sterling

BNP Paribas (QX)

Bank of America

Gold vs US Dollar

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約